Lithium Carbonate Tablet, Extended Release
Product Images NDC 64980-205

4 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 64980-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lithium Fi-1 (Lithium Fi 1)

Lithium Fi-1 (Lithium Fi 1)
A data table titled 'Acute Mania' showing a dosing schedule for lithium carbonate extended-release tablets. The table specifies administration of 3 tablets (900 mg) each in the morning, afternoon, and nighttime. A footnote notes that dosing can also be given as 600 mg three times daily at recommended intervals.*
FDA Label Image

Litium Fi-2 (Litium Fi 2)

Litium Fi-2 (Litium Fi 2)
A labeled dosing schedule table for lithium carbonate extended-release tablets, showing long-term control doses of 2 tablets (600 mg) in the morning and 2 tablets (600 mg) at nighttime, with no dose listed for the afternoon.*
FDA Label Image
Image Description (Rising Logo)
FDA Label Image

500ct Label.jpg (500ct Label)

500ct Label.jpg (500ct Label)
Label for Lithium Carbonate Extended-Release Tablets USP, 300 mg, oral tablets in a 500 count package. Manufactured by Unique Pharmaceutical Laboratories in India and distributed by Rising Pharma Holdings, Inc. The label includes dosage form, strength, storage instructions, and a barcode. The product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.